1. Home
  2. TNDM

as 11-15-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Founded: 2006 Country:
United States
United States
Employees: N/A City: San Diego
Market Cap: 1.9B IPO Year: 2013
Target Price: $52.50 AVG Volume (30 days): 1.6M
Analyst Decision: Buy Number of Analysts: 16
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.94 EPS Growth: N/A
52 Week Low/High: $17.33 - $53.69 Next Earning Date: 11-06-2024
Revenue: $854,351,000 Revenue Growth: 10.75%
Revenue Growth (this year): 23.61% Revenue Growth (next year): 10.79%

TNDM Daily Stock ML Predictions

Share on Social Networks: